DarshanTalks Podcast
by Darshan Kulkarni
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇵🇱PL · Life Sciences#124500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
150 to 900🎙 Daily cadence·342 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇵🇱100% - Active Followers
Loyal subscribers who consistently listen
150 to 900
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 15 epsHosts
Recent guests
Recent episodes
Pharmacy's Critical Role in Clinical Trial Compliance
Jul 16, 2026
15m 18s
The Wild Lizard Venom Origins of Ozempic
Jul 8, 2026
4m 36s
Unlicensed Medical Advice & The Legal Battle Over Character.AI
May 18, 2026
15m 25s
Sponsoring Cannabis Research
May 6, 2026
4m 47s
The New Era of Personal Consent Decrees
Apr 30, 2026
8m 04s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/16/26 | clinical trialspharmacy+3 | Tom Sepka | HCI Healthcare Consultants | — | clinical trial complianceresearch pharmacy+3 | — | 15m 18s | ||
| 7/8/26 | pharmaceuticalsbiotechnology+3 | — | OzempicWegovy+1 | — | OzempicWegovy+5 | — | 4m 36s | ||
| 5/18/26 | artificial intelligencemedical advice+4 | Elizabeth Litten | Fox RothschildCharacter.AI | Pennsylvania | AI chatbotmedical license+5 | — | 15m 25s | ||
| 5/6/26 | cannabis researchlegalization+4 | — | cannabisSchedule I+1 | U.S. | cannabisresearch+5 | — | 4m 47s | ||
| 4/30/26 | personal consent decreesfederal enforcement+4 | — | Office of Data ReliabilityKLF Playbook+1 | — | consent decreefederal enforcement+4 | — | 8m 04s | ||
| 4/16/26 | Private Membership AssociationFDA oversight+4 | — | FDALittle v. Q Lasers | — | Private Membership AssociationFDA+5 | — | 7m 03s | ||
| 4/11/26 | clinical trialsrecruitment+3 | — | KLFstate licensing boards+2 | — | clinical trialrecruitment fees+5 | — | 7m 57s | ||
| 4/10/26 | clinical trialslegal architecture+3 | — | — | — | clinical trial sitesproprietary data+3 | — | 1m 06s | ||
| 4/9/26 | compounded drugsFDA approval+3 | — | Mounjaro | — | compounded drugsFDA approval+4 | — | 2m 24s | ||
| 4/6/26 | compliancelife sciences+4 | — | OIGlife sciences | — | compliance theatercontract sales forces+3 | — | 3m 51s | ||
| 4/3/26 | AI in clinical researchdata integrity+4 | — | — | — | AIclinical research+4 | — | 0m 45s | ||
| 4/2/26 | AI in drug discoverybiotech risks+4 | — | — | — | AI-generated drugspatentable+5 | — | 3m 26s | ||
| 3/30/26 | AI in healthcaremedical technology+3 | — | New York TimesNature Medicine | — | AIdoctor+7 | — | 12m 57s | ||
| 3/28/26 | pharmaceutical marketinghealthcare policy+3 | — | HHS Office of Inspector GeneralTrumpRx | — | OIGpharmaceutical marketing+3 | — | 0m 53s | ||
| 3/27/26 | bulk datafederal court+4 | — | DOJ | China | bulk sensitive personal datafederal violation+4 | — | 0m 42s |
Showing 15 of 15
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for DarshanTalks Podcast
Peaked at #124 in PL, currently #124 in PL.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| PL | — | #124 | #124 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.